Immunotherapy of Murine Sarcomas Using Lymphokine Activated Killer Cells: Optimization of the Schedule and Route of Administration of Recombinant Interleukin-2

Stephen E. Ettinghausen, Steven A. Rosenberg

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Immunotherapy of Murine Sarcomas Using Lymphokine Activated Killer Cells: Optimization of the Schedule and Route of Administration of Recombinant Interleukin-2'. Together they form a unique fingerprint.

Medicine & Life Sciences